7.62
2.83%
0.21
Regenxbio Inc (RGNX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
29.67%
15.62
|
22.21 | 28.91 | 19.98 | 19.14 |
Cost Of Revenue |
61.89%
4.283
|
11.24 | 12.39 | 9.475 | 4.112 |
Gross Profit |
3.32%
11.34
|
10.97 | 16.53 | 10.50 | 15.03 |
Operating Expenses
|
0.43%
75.20
|
74.88 | 81.49 | 83.61 | 81.18 |
Interest Income/Expense |
44.75%
1.973
|
1.363 | 1.624 | 1.12 | 2.755 |
Benefits Costs and Expenses |
7.39%
78.95
|
85.25 | 90.78 | 92.04 | 85.81 |
Costs And Expenses |
7.70%
79.48
|
86.12 | 93.87 | 93.08 | 85.30 |
Depreciation and Amortization |
3.58%
4.18
|
4.335 | 4.372 | 4.435 | 4.178 |
Operating Income/Loss |
0.06%
-63.86
|
-63.90 | -64.96 | -73.11 | -66.16 |
Nonoperating Income/Loss |
38.17%
0.533
|
0.862 | 3.092 | 1.047 | -0.519 |
Income/Loss From Continuing Operations Before Tax |
0.46%
-63.33
|
-63.04 | -61.87 | -72.06 | -66.68 |
Income/Loss From Continuing Operations After Tax |
0.70%
-63.33
|
-62.89 | -61.87 | -72.06 | -66.68 |
Net Income/Loss
|
0.70%
-63.33
|
-62.89 | -61.87 | -72.06 | -66.68 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4.68%
45.73
|
43.69 | 0.0439 | 0.0435 | 0.0435 |
Diluted Average Shares |
4.68%
45.73
|
43.69 | 0.0439 | 0.0435 | 0.0435 |
Basic Earnings Per Share |
2.82%
-1.38
|
-1.42 | -1.41 | -1.66 | -1.53 |
Diluted Earnings Per Share |
2.82%
-1.38
|
-1.42 | -1.41 | -1.66 | -1.53 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):